Inhibitors of the PI3 kinase family of enzymes show promise for treating brain tumors.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
British Journal of Cancer Open Access 24 March 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Workman, P. Cold Spring Harbor Quant. Biol. 70, 1–18 (2005).
Shaw, R.J. & Cantley, L.C. Nature 441, 424–430 (2006).
Knight, Z.A. et al. Cell 125, 1–15 (2006).
Fan Q.W et al. Cancer Cell 9, 341–349 (2006).
Foukas, L.C. et al. Nature 441, 366–370 (2006).
Samuels, Y. et al. Science 23, 304 (2004).
Vivanco, I. & Sawyers, C.L. Nat. Rev. Cancer 2, 489–501 (2002).
Workman, P. et al. Eur. J. Cancer 2, 8 (Suppl) (2004).
O'Reilly, K.E. et al. Cancer Res. 66, 1500–1508 (2006).
Sabassov, D.D. et al. Science 307, 1098–1101 (2005).
Feng, J. et al. J. Biol. Chem. 279, 41189–41196 (2004).
Yaguchi, S. et al. J. Natl. Cancer Inst. 98, 545–556 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Workman, P., Clarke, P., Guillard, S. et al. Drugging the PI3 kinome. Nat Biotechnol 24, 794–796 (2006). https://doi.org/10.1038/nbt0706-794
Issue Date:
DOI: https://doi.org/10.1038/nbt0706-794
This article is cited by
-
Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells
Journal of Neuro-Oncology (2014)
-
Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases
Investigational New Drugs (2013)
-
Evaluation of 2-Deoxy-2-[18F]Fluoro-D-glucose- and 3′-Deoxy-3′-[18F]Fluorothymidine–Positron Emission Tomography as Biomarkers of Therapy Response in Platinum-Resistant Ovarian Cancer
Molecular Imaging and Biology (2012)
-
The PI3K/AKT/mTOR Signaling Pathway: Implications in the Treatment of Breast Cancer
Current Breast Cancer Reports (2011)
-
Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
British Journal of Cancer (2009)